Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors

Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors

Abstract Background Patients who developed immune-related adverse events (irAEs) could benefit more from treatment with immune checkpoint inhibitors (ICIs) than those who did not develop irAEs. This study was designed to assess whether the occurrence of irAEs or their characteristics are correlated...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyue Han, Yingcui Chen, Hong Xie, Yuekai Zhang, Yu Cui, Yaping Guan, Weiwei Nie, Qi Xie, Jisheng Li, Baocheng Wang, Bicheng Zhang, Jun Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Immune-related adverse events
Immune checkpoint inhibitor
Organ specific
Prognosis
Advanced cancer
Online Access:https://doi.org/10.1186/s12885-025-13566-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items